Search results
Results from the WOW.Com Content Network
It is the goal of epigenetic therapies to inhibit these alterations. DNA Methyltransferases (DNMTs) and Histone Deacetylases (HDAC) are the primary catalyzes of the epigenetic modifications of cancer cells. [145] The goal for epigenetic therapies is to repress this methylation and reverse these modifications in order to create a new epigenome ...
Many tumor suppressors work to regulate the cycle at specific checkpoints in order to prevent damaged cells from replicating. A tumor suppressor gene (TSG), or anti-oncogene, is a gene that regulates a cell during cell division and replication. [1] If the cell grows uncontrollably, it will result in cancer. When a tumor suppressor gene is ...
Cancer research is research into cancer to identify causes and develop strategies for prevention, diagnosis, treatment, and cure. Cancer research ranges from epidemiology, molecular bioscience to the performance of clinical trials to evaluate and compare applications of the various cancer treatments.
The article Epigenetic inactivation of the premature aging Werner syndrome gene in human cancer indicates the DNA repair gene WRN has a promoter that is frequently hypermethylated in a number of cancers, with hypermethylation occurring in 11% to 38% of colorectal, head and neck, stomach, prostate, breast, thyroid, non-Hodgkin lymphoma ...
Histone modifications play an important role in the regulation of cellular processes, thus epigenetic changes resulting in changed structure can lead to abnormal transcription, DNA repair and replication. [17] Below are some examples and then an overview of the ways these epigenetic modifications are being targeted.
Both DNA methylation and histone modifications show patterns of distribution in cancer cells. [39] [40] These epigenetic alterations may occur at different stages of tumourigenesis and thus contribute to both the development and/or progression of cancer. [40]
“Epigenetic memory is well-known for explaining how daughter-cells maintain their transcriptional identity through cell division, playing a vital role in development, regeneration, and growth ...
In cancer cells, where normal regulation of gene expression breaks down, the oncogenes are activated via hypomethylation and tumor suppressors are silenced via hypermethylation. Similarly, in drug resistance development, it has been suggested that epigenetic modifications can result in the activation and overexpression of pro-drug resistance genes.